Towards DNA methylation detection using biosensors.

Area of Science:

• Biochemistry
• Molecular Biology
• Biomedical Engineering

Background:

• DNA methylation, a heritable epigenetic modification, is a promising biomarker for disease detection, prognosis, and treatment response prediction.
• Methylated DNA can be detected in various body fluids, enabling non-invasive diagnostics.
• Classical DNA methylation detection methods face challenges including high costs, complex protocols, low sensitivity, and high false positive rates.

Purpose of the Study:

• To review conventional DNA methylation detection techniques.
• To highlight recent advancements in biosensor-based DNA methylation detection.
• To focus on biosensors that bypass bisulfite conversion and PCR amplification.

Main Methods:

• Overview of established DNA methylation detection methodologies.
• Exploration of emerging biosensor technologies for methylation analysis.
• Emphasis on label-free and amplification-free biosensing approaches.

Main Results:

• Traditional methods for DNA methylation analysis are often expensive, time-consuming, and lack sensitivity.
• Biosensors offer a promising alternative, providing portable, simple, rapid, and cost-effective detection of methylated DNA biomarkers.
• Recent biosensor developments eliminate the need for bisulfite conversion and PCR amplification, streamlining the detection process.

Conclusions:

• Biosensors represent a significant advancement for DNA methylation biomarker detection, addressing limitations of conventional techniques.
• The development of sensitive, fast, and cost-effective biosensors is crucial for advancing non-invasive disease diagnostics and personalized medicine.
• Future research should focus on further refining biosensor technology for widespread clinical application in DNA methylation analysis.